Archive - January 2020
NICE knocks back Roche’s Tecentriq for small cell lung cancer
Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal
Boehringer Ingelheim to manufacture first biologic in China under new reforms
Vaccitech, CR UK link up to develop NSCLC drug
NHS diabetes drive sees public lose ‘weight of 43 ambulances’
Late-stage success for experimental migraine drug
‘Half’ the current chemo could prevent testicular cancer returning
Tecentriq hit with draft NICE rejection